These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29512779)
1. Suppression of YAP by DDP disrupts colon tumor progression. Li K; Guo J; Wu Y; Jin D; Jiang H; Liu C; Qin C Oncol Rep; 2018 May; 39(5):2114-2126. PubMed ID: 29512779 [TBL] [Abstract][Full Text] [Related]
2. Repression of YAP by NCTD disrupts NSCLC progression. Guo J; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Li X; Xi S Oncotarget; 2017 Jan; 8(2):2307-2319. PubMed ID: 27903989 [TBL] [Abstract][Full Text] [Related]
3. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892 [TBL] [Abstract][Full Text] [Related]
4. Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non‑small lung cancer cells by regulating the YAP pathway. Jin D; Wu Y; Shao C; Gao Y; Wang D; Guo J Oncol Rep; 2018 Aug; 40(2):609-620. PubMed ID: 29901163 [TBL] [Abstract][Full Text] [Related]
5. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501 [TBL] [Abstract][Full Text] [Related]
6. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation. Zhou J; Zeng Y; Cui L; Chen X; Stauffer S; Wang Z; Yu F; Lele SM; Talmon GA; Black AR; Chen Y; Dong J Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6760-E6769. PubMed ID: 29967145 [TBL] [Abstract][Full Text] [Related]
7. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression. Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336 [TBL] [Abstract][Full Text] [Related]
8. Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines. Ferraiuolo M; Pulito C; Finch-Edmondson M; Korita E; Maidecchi A; Donzelli S; Muti P; Serra M; Sudol M; Strano S; Blandino G Cancer Lett; 2018 Oct; 433():18-32. PubMed ID: 29933048 [TBL] [Abstract][Full Text] [Related]
9. miR-550a-3-5p acts as a tumor suppressor and reverses BRAF inhibitor resistance through the direct targeting of YAP. Choe MH; Yoon Y; Kim J; Hwang SG; Han YH; Kim JS Cell Death Dis; 2018 May; 9(6):640. PubMed ID: 29844307 [TBL] [Abstract][Full Text] [Related]
10. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner. Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway. Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911 [TBL] [Abstract][Full Text] [Related]
12. Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse. Corvaisier M; Bauzone M; Corfiotti F; Renaud F; El Amrani M; Monté D; Truant S; Leteurtre E; Formstecher P; Van Seuningen I; Gespach C; Huet G Oncotarget; 2016 Aug; 7(35):56699-56712. PubMed ID: 27527859 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells. Zhou X; Su J; Feng S; Wang L; Yin X; Yan J; Wang Z Oncotarget; 2016 Nov; 7(48):79076-79088. PubMed ID: 27738325 [TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells. Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500 [TBL] [Abstract][Full Text] [Related]
15. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells. Ma L; Cui J; Xi H; Bian S; Wei B; Chen L Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609 [TBL] [Abstract][Full Text] [Related]
16. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway. Zhang Y; Yuan J; Zhang X; Yan F; Huang M; Wang T; Zheng X; Zhang M Oncol Rep; 2016 Dec; 36(6):3619-3626. PubMed ID: 27779692 [TBL] [Abstract][Full Text] [Related]
17. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma. Yang C; Tan J; Zhu J; Wang S; Wei G Oncotarget; 2017 Jun; 8(23):37154-37163. PubMed ID: 28415761 [TBL] [Abstract][Full Text] [Related]
18. Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit. Kuo CC; Ling HH; Chiang MC; Chung CH; Lee WY; Chu CY; Wu YC; Chen CH; Lai YW; Tsai IL; Cheng CH; Lin CW Theranostics; 2019; 9(9):2526-2540. PubMed ID: 31131051 [No Abstract] [Full Text] [Related]
19. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma. Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049 [TBL] [Abstract][Full Text] [Related]
20. Yes-associated protein (YAP) expression is involved in epithelial-mesenchymal transition in hepatocellular carcinoma. Wang S; Li H; Wang G; Zhang T; Fu B; Ma M; Quan Z; Chen G Clin Transl Oncol; 2016 Feb; 18(2):172-7. PubMed ID: 26254048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]